Retabolil (nandrolone decanoate) solution for injections 50 mg/ml. 1ml. ampoules №1


Period of convalescence. Anemia due to chronic kidney failure.



Composition and form of release Retabolil 
Main active ingredients: 1 ml of the drug contains 50 mg of nandrolone decanoate.
Auxiliary components: benzyl alcohol, isopropyl alcohol, sunflower oil.
The drug is sold as an oily injection.

Pharmacological properties

The specified drug is included in the group of anabolic drugs used systemically.
The active ingredient is a synthetic testosterone derivative, in which the androgenic effect is weakened, but the anabolic effect is enhanced. The latter of them can be manifested by activating repair processes in epithelial, bone and muscle tissues by stimulating the processes of protein synthesis and components of cellular structures.
The medicine increases the absorption of amino acids from the small intestine. This effect creates a positive nitrogen balance.
The active substance of the drug promotes the production of erythropoietin and the activation of anabolic processes in the bone marrow. The combination of the drug with iron preparations has an antianemic effect.
A concomitant effect of the drug is to suppress the synthesis of gonadotropins and endogenous testosterone.

The drug Retabolil is prescribed in the following cases:

  • convalescence period;
  • anemia due to chronic renal failure.

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.
The drug is contraindicated for use with:

  • prostate cancer;
  • breast cancer in men;
  • breast carcinoma in women with hypercalcemia;
  • Ischemic heart disease;
  • severe atherosclerosis;
  • nephrotic syndrome;
  • acute and chronic liver diseases; incl. alcoholic lesions;
  • nephritis.

The drug is not used in pediatrics.

Application during pregnancy and lactation
This drug is not recommended for pregnant women – only under strict indications determined by the attending physician.

If it is necessary to take the drug during breastfeeding, lactation is suspended.

Method of administration and dosage
The drug Retabolil is used intramuscularly: for men – 200 mg once a week, for women – 100 mg once a week.
The therapeutic effect is individual.
Treatment should be discontinued in the absence of a therapeutic effect after 3-6 months of use.
After a corresponding improvement in the blood picture or its normalization, the dose should be gradually reduced, regularly monitoring hematological parameters. Deterioration in performance with dose reduction or after the end of treatment may be an indication for resuming treatment.

The drug is usually well tolerated when used in the recommended doses.
In case of an overdose, the following symptoms may occur: severe endocrine, metabolic and mental side reactions.

Side effects:

The drug is usually well tolerated when used in the recommended doses.

Allergy may occur in case of individual intolerance. In particular, it can be observed:

  • in women – symptoms of virilization, inhibition of ovarian function, menstrual irregularities, hypercalcemia;
  • in men – bladder irritation, gynecomastia, priapism;
  • in old age, prostate hypertrophy and / or carcinoma.

Storage conditions and periods
Expiration date – up to 5 years from the production date indicated on the package. Storage periods should not be exceeded.
Storage temperature should not exceed 25 ° C. Temperature deviations can change the properties of the preparation, therefore it should always be stored in its original packaging.